Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ECOG-ACRIN Cancer Research Group is a premier multidisciplinary cancer research organization that designs and conducts large-scale biomarker-driven clinical trials. Formed in 2012 through the merger of the Eastern Cooperative Oncology Group (ECOG) and the American College of Radiology Imaging Network (ACRIN), the group uniquely integrates therapeutic research with advanced medical imaging. It functions as a core member of the NCI National Clinical Trials Network (NCTN) and the NCI Community Oncology Research Program (NCORP). ECOG-ACRIN is renowned for landmark studies such as NCI-MATCH and the TAILORx trial, which have significantly influenced the standard of care in oncology. The organization leverages a vast network of nearly 1,300 member institutions and thousands of investigators to advance precision medicine. Its research portfolio spans the cancer care spectrum, including prevention, screening, and treatment across all major cancer types.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ECOG-ACRIN Medical Research Foundation.